The long-awaited closing of Amgen’s nearly $28 billion deal for Horizon Therapeutics boosted the pharma giant’s latest quarterly earnings released Tuesday afternoon.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,